A second novel finding from this study is that serum MDK has superior diagnostic performance to AFP in the detection of NASH-HCC (AUROC 0.86; 95% CI 0.72–1.0 versus 0.76; 95% CI 0.58–0.95). Here, MDK is linked to metabolic dysfunction-associated steatohepatitis.